ABBVIE INC (ABBV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ABBV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ABBV | Director | 71 | ["Retired Executive Vice President, Finance and Administration at Abbott Laboratories", "Director at Allergan from 2018 to 2020", "Executive Vice President, Finance and Administration at Abbott Laboratories from 2015 to 2017", "Chief Financial Officer and Executive Vice President at Abbott", "Director of Tenneco Inc. from 2013 to 2022", "Director of Hanger, Inc. from 2017 to 2022", "Extensive experience in health care and finance", "Expertise in complex accounting and financial issues", "Manufacturing and environmental, health, and safety oversight experience"] | ["Compensation", "Nominations & Governance"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Freyman served as a director at Allergan from 2018 to 2020, when AbbVie acquired Allergan plc. Mr. Freyman previously served as Executive Vice President, Finance and Administration at Abbott Laboratories from 2015 until his retirement in 2017. He previously served at Abbott as Chief Financial Officer and Executive Vice President, Finance and was first appointed Chief Financial Officer and Senior Vice President, Finance in 2001. Mr. Freyman previously served as a director of Tenneco Inc. from 2013 to 2022 and Hanger, Inc. from 2017 to 2022.